MEDI4166 / AstraZeneca  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MEDI4166 / AstraZeneca
NCT02524782: A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 Diabetes

Completed
1
103
US
MEDI-4166, Placebo
MedImmune LLC
Type 2 Diabetes
04/17
04/17

Download Options